Custom Care for Kids: Pharmacogenomics in Pediatrics | Pediatric Pharmacist Review

Pharmacy Podcast Network

In this exciting episode of the Pediatric Pharmacist Review Podcast, we’re diving into the fascinating world of pharmacogenomics and its transformative impact on pediatric care. Our special guest is Dr. Kelly E. Caudle, Pharm.D., Ph.D., FCCP, an Associate Member in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children’s Research Hospital.
Dr. Caudle brings a wealth of expertise to the discussion, with over a decade of experience in pharmacogenomics implementation. As the Director of the NIH-funded Clinical Pharmacogenetics Implementation Consortium (CPIC), she oversees groundbreaking work in translating genetic test results into actionable prescribing decisions. With CPIC publishing 28 gene-based clinical guidelines covering 29 genes and over 150 drugs, Dr. Caudle's leadership is reshaping personalized medicine for children worldwide.
Tune in as we explore how pharmacogenomics is enabling tailored treatments for pediatric patients, improving medication efficacy, and minimizing adverse effects. Dr. Caudle also shares insights into her work at St. Jude Children's Research Hospital and offers a glimpse into the future of personalized pediatric care.
Key Takeaways:
What pharmacogenomics is and why it matters for pediatric medicine.
How CPIC guidelines are helping clinicians make data-driven prescribing decisions.
The role of genetic testing in improving medication safety and outcomes for children.
Dr. Caudle’s journey in leading pharmacogenomics research and clinical implementation.
Guest Bio:
Dr. Kelly E. Caudle is a leading expert in pharmacogenomics, with over 100 publications and abstracts to her name. Her work has advanced the clinical implementation of pharmacogenetics at St. Jude Children’s Research Hospital and beyond. As a passionate researcher and educator, she has inspired countless professionals through her national and international presentations.